Paresh Soni

Q: What is Paresh Soni email address?

Email Paresh Soni at paresh@corvidane.com. This email is the most updated Paresh Soni email found in 2026.

Q: How to contact Paresh Soni?

To contact Paresh Soni send an email to paresh@corvidane.com. (updated on November 04, 2024)

CEO and Board member at Corvidane | New London County, Connecticut, United States

About Paresh Soni

Paresh Soni, as the CEO and Board member of Corvidane, brings a wealth of expertise and a robust background in both large and small pharmaceutical environments. His extensive experience spans the entire drug development spectrum, from translational medicine to successful regulatory approvals, making him a pivotal figure in the biotechnology landscape. With board certifications in internal medicine and gastroenterology, Paresh has honed his skills in leading global multidisciplinary project teams, particularly in the development of innovative therapies for liver diseases.

At Corvidane, Paresh is at the forefront of groundbreaking initiatives aimed at addressing some of the most pressing health challenges worldwide. The company’s flagship project, Corvida™, is designed to prevent heart attacks and strokes—two of the leading causes of mortality globally—as well as to tackle the rising incidence of liver transplants in the United States. Under his leadership, Corvidane is leveraging cutting-edge clinical research methodologies and advanced drug development strategies to bring transformative solutions to the market.

Paresh's proven track record in medical affairs and clinical trials, combined with his deep understanding of the pharmaceutical industry, positions him uniquely to navigate the complexities of drug development. His commitment to advancing public health through innovative therapeutics is evident in his strategic vision for Corvidane, where he fosters a culture of collaboration and scientific excellence. As the company continues to progress through critical phases of clinical trials, Paresh remains dedicated to ensuring that Corvidane not only meets regulatory standards but also delivers impactful therapies that improve patient outcomes on a global scale.

Paresh Soni Work